陕西盘龙药业集团股份有限公司关于注销部分募集资金账户的公告

Fundraising Overview - The company raised a total of RMB 301,999,974.60 by issuing 9,352,740 shares at a price of RMB 32.29 per share on September 19, 2023 [1] - After deducting underwriting fees and other related expenses, the net amount raised was RMB 294,836,292.23 [1] Fund Management - The company has established a fundraising management system in compliance with relevant laws and regulations to ensure efficient use of funds and protect investor rights [3] - A tripartite supervision agreement was signed with the sponsor and banks to manage the raised funds [3] Account Closure - The account used for the "Traditional Chinese Medicine Formula Granule R&D and Industrialization Project" was closed on February 4, 2026, as the balance was zero after funds were permanently transferred to working capital [3]